Annual Debt To Equity
0.75
-0.01-1.32%
31 December 2023
Summary:
Innate Pharma SA annual debt to equity ratio is currently 0.75, with the most recent change of -0.01 (-1.32%) on 31 December 2023. During the last 3 years, it has risen by +0.65 (+650.00%). IPHA annual debt to equity is now -1.32% below its all-time high of 0.76, reached on 31 December 2022.IPHA Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
1.23
+0.48+64.00%
30 June 2024
Summary:
Innate Pharma SA quarterly debt to equity ratio is currently 1.23, with the most recent change of +0.48 (+64.00%) on 30 June 2024. Over the past year, it has increased by +0.53 (+75.71%). IPHA quarterly debt to equity is now at all-time high.IPHA Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Debt To Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1.3% | +75.7% |
3 y3 years | +650.0% | +925.0% |
5 y5 years | +7400.0% | - |
IPHA Debt To Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -1.3% | +650.0% | at high | +925.0% |
5 y | 5 years | -1.3% | +7400.0% | at high | +1657.1% |
alltime | all time | -1.3% | at high |
Innate Pharma SA Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | 1.23(+64.0%) |
Dec 2023 | 0.75(-1.3%) | 0.75(+7.1%) |
June 2023 | - | 0.70(-7.9%) |
Dec 2022 | 0.76(+94.9%) | 0.76(+105.4%) |
June 2022 | - | 0.37(-5.1%) |
Dec 2021 | 0.39(+290.0%) | 0.39(+225.0%) |
June 2021 | - | 0.12(+20.0%) |
Dec 2020 | 0.10(+42.9%) | 0.10(+11.1%) |
June 2020 | - | 0.09(+28.6%) |
Dec 2019 | 0.07(+600.0%) | 0.07(+600.0%) |
June 2019 | - | 0.01(0.0%) |
Dec 2018 | 0.01(-66.7%) | 0.01(0.0%) |
June 2018 | - | 0.01(-66.7%) |
Dec 2017 | 0.03(+50.0%) | 0.03(+50.0%) |
June 2017 | - | 0.02(0.0%) |
Dec 2016 | 0.02(0.0%) | 0.02(0.0%) |
June 2016 | - | 0.02(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | 0.02(0.0%) | 0.02(0.0%) |
June 2015 | - | 0.02(0.0%) |
Dec 2014 | 0.02(-50.0%) | 0.02(0.0%) |
June 2014 | - | 0.02(-50.0%) |
Dec 2013 | 0.04(+33.3%) | 0.04(+33.3%) |
June 2013 | - | 0.03(0.0%) |
Dec 2012 | 0.03(-66.7%) | 0.03(>+9900.0%) |
June 2012 | - | 0.00(-100.0%) |
Dec 2011 | 0.09(-55.0%) | 0.09(>+9900.0%) |
June 2011 | - | 0.00(-100.0%) |
Dec 2010 | 0.20(+25.0%) | 0.20(>+9900.0%) |
June 2010 | - | 0.00(-100.0%) |
Dec 2009 | 0.16(-5.9%) | 0.16 |
Dec 2008 | 0.17(>+9900.0%) | - |
Dec 2007 | 0.00(0.0%) | - |
Dec 2006 | 0.00(0.0%) | - |
Dec 2005 | 0.00 | - |
FAQ
- What is Innate Pharma SA annual debt to equity ratio?
- What is the all time high annual debt to equity for Innate Pharma SA?
- What is Innate Pharma SA annual debt to equity year-on-year change?
- What is Innate Pharma SA quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Innate Pharma SA?
- What is Innate Pharma SA quarterly debt to equity year-on-year change?
What is Innate Pharma SA annual debt to equity ratio?
The current annual debt to equity of IPHA is 0.75
What is the all time high annual debt to equity for Innate Pharma SA?
Innate Pharma SA all-time high annual debt to equity ratio is 0.76
What is Innate Pharma SA annual debt to equity year-on-year change?
Over the past year, IPHA annual debt to equity ratio has changed by -0.01 (-1.32%)
What is Innate Pharma SA quarterly debt to equity ratio?
The current quarterly debt to equity of IPHA is 1.23
What is the all time high quarterly debt to equity for Innate Pharma SA?
Innate Pharma SA all-time high quarterly debt to equity ratio is 1.23
What is Innate Pharma SA quarterly debt to equity year-on-year change?
Over the past year, IPHA quarterly debt to equity ratio has changed by +0.53 (+75.71%)